mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.4 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.4 |